Business & Regulation COVID-19, Quality & Compliance, Business Practice, Supply Chain

From Quality Control to Cold Chain: What the Pandemic Taught Us

The world wasn’t ready for COVID-19. But if we learn the right lessons, next time we’ll do better.

06/08/2022 | Video

We all know the last two and more years have not been normal, or easy. But like many of us, perhaps you feel that you have learned something – either about yourself, or the world around you. Across the pharmaceutical industry, the feeling is mutual. In this sponsored video, Datwyler breaks down the four key lessons to walk away with in the aftermath of the COVID-19 pandemic. Transparency, risk management, quality control, and risk reduction. These are the factors that will make the difference when (not if) the next pandemic strikes.

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.